From: Colon adenoma and adenocarcinoma with clear cell components - two case reports
Antibody | Clone | Company | Dilution | Conditioning |
---|---|---|---|---|
CK7 | OV-TL 12/30 | DAKO, Santa Clara, USA | 1:50 | Protease |
CK20 | Ks 20.8 | DAKO, Santa Clara, USA | 1:50 | Protease |
CDX2 | AMT28 | Novus Biologicals, Newcastle, UK | 1:50 | pH 9.0 |
CEA | II-7 | DAKO, Santa Clara, USA | 1:40 | pH 6.0 |
CD10 | 56C6 | Novocastra, Newcastle, UK | 1:50 | pH 6.0 overnight |
MUC2 | Ccp58 | Novocastra, Newcastle, UK | 1:100 | pH 6.0 |
MUC5AC | CLH2 | Abcam, Cambridge, UK | 1:1000 | Â |
MUC6 | CLH5 | Novocastra, Newcastle, UK | 1:100 | pH 6.0 |
AFP | N1501 | DAKO, Santa Clara, USA | diluted | Â |
Glypican3 | 1G12 | Nichirei Bioscience, Tokyo, Japan | diluted | pH 9.0 |
AR | AR441 | DAKO, Santa Clara, USA | 1:25 | pH 6.0 |
Perilipin | GP29 | PROGEN, Heidelberg, Germany | 1:200 | pH 6.0 |
Adipophilin | AP125 | Acris Antibodies, Herford, Germany | 1:10 | pH 6.0 |
Ki67 | MIB-1 | DAKO, Santa Clara, USA | 1:50 | pH 6.0 |
COX2 | CX-294 | DAKO, Santa Clara, USA | 1:100 | pH 9.0 |
APC | CC-1 | Oncogene, California, USA | 1:20 | pH 6.0 |